Evommune, Inc. EVMN

Full chart Compare
Set alert

Price alert · EVMN

All alert types
6.04 USD +0.10 (+1.68%)

At closeNov 4, 2026, 7:34 PM EST

6.54 +0.50 +8.28%

After hours · Nov 4, 7:34 PM ET

5.82 Day range 6.30
5.10 52-week range 31.57
YTD
-64.72%
1 year
-70.14%

Revenue & Expenses

Other Income → Expenses: $12.20MExpenses → Selling, General & Admin: $20.03MExpenses → Research & Development: $74.04MGross Profit → Expenses: $13.00MRevenue → Gross Profit: $13.00MNet Loss → Expenses: $68.87MOther Income$12.20MGross Profit$13.00MNet Loss$68.87MExpenses$94.07MSelling, General & Admin$20.03MResearch & Development$74.04MRevenue$13.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EVMN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
13.00M7.00M5.00M
13.00M7.00M5.00M
-81.07M-70.01M-37.85M
-68.87M-66.81M-34.05M
-11.22-45.29-3.19
EVMN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
45.48M16.46M29.23M
224.95M76.06M82.25M
19.38M28.52M10.59M
1.71M1.02M1.26M
205.57M-144.24M-77.71M
EVMN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
-76.44M-58.20M-29.97M
-115.31M-3.99M-48.43M
220.76M49.42M63.75M
-235.00K-88.00K-118.00K
29.02M-12.77M-14.65M